Tamiflu Reduced Risk of Death by 25% in Patients Hospitalised with H1N1

A meta-analysis published online today in The Lancet Respiratory Medicine has concluded that patients admitted to hospital with H1N1 influenza during the 2009/2010 pandemic were 25% less likely to die from the disease if they had been given neuraminidase inhibitors (NAIs) such as Roche’s Tamilfu. Until now, [Governments] had no adequate data to assist them in deciding if lives were saved in 2009-2010 …